Advanced Lipoprotein Profiling by Nuclear Magnetic Resonance.
It consists on CE-marked test, using in vitro diagnostic tool that leverages nuclear magnetic resonance (NMR) spectroscopy to provide a detailed, quantitative characterization of lipoprotein particles, including their size, number, and subclass distribution across the main lipoprotein classes: VLDL, LDL, and HDL.
Unlike conventional lipid panels that measure only total cholesterol and triglyceride concentrations, Liposcale offers advanced lipoprotein profiling that enables clinicians and researchers to gain a deeper understanding of a patient’s cardiovascular and metabolic risk profile.
This includes the quantification of small dense LDL particles and other parameters associated with atherosclerotic risk and insulin resistance, which are often overlooked in routine clinical testing. The Liposcale test plays a valuable role in precision medicine, particularly in the early detection and monitoring of cardiometabolic diseases, where detailed lipoprotein metrics can support personalized prevention and treatment strategies.
It is especially useful in individuals with metabolic disorders, residual cardiovascular risk despite normal lipid values, or those undergoing lifestyle or pharmacological interventions.
✔️ CE-IVD certified
✔️ High reproducibility and scalability
✔️ Ready for integration in clinical workflows and research pipelines